2015-10-07T07:52:00-05:00 2014-12-31 410746749 CLIFTONLARSONALLEN LLP 4250 N FAIRFAX DRIVE SUITE 1020 ARLINGTON VA 22203 990 2014-01-01 264188804 COUNCIL FOR BIOTECHNOLOGY INFORMATION COUN 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 KATE HALL INTERIM EXECUTIVE DIRECTOR 2029629200 2015-09-24 1 MARY ANNE HAKIM P00236052 5712279500 2014 2016-02-25 16:41:14Z KATE HALL 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 9820173 0 X WWW.GMOANSWERS.COM X 2008 DC TO PROMOTE AGRICULTURAL PLANT BIOTECHNOLOGY THROUGH THE EXCHANGE OF INFORMATION ABOUT ITS BENEFITS AND SAFETY AND THROUGH RESEARCH, EDUCATION, ADVOCACY AND OTHER MEANS IN THE UNITED STATES, CANADA, AND MEXICO 6 6 0 6 0 0 0 0 5391750 9817674 1311 2499 0 0 5393061 9820173 624361 302521 0 0 0 0 0 0 0 4358393 7214623 4982754 7517144 410307 2303029 1668526 3407392 730082 165919 938444 3241473 X TO PROMOTE AGRICULTURAL PLANT BIOTECHNOLOGY THROUGH THE EXCHANGE OF INFORMATION ABOUT ITS BENEFITS AND SAFETY AND THROUGH RESEARCH, EDUCATION, ADVOCACY AND OTHER MEANS IN THE UNITED STATES, CANADA, AND MEXICO. 0 0 GMO ANSWERS - CONTINUED DEVELOPMENT AND EXPANDED OUTREACH FOR THE GMO ANSWERS PROGRAM AND WEBSITE. STATE AND MEDIA RELATIONS - PROVIDED SUPPORT FOR LOBBYING, EDUCATION, OUTREACH, AND OTHER STRATEGIES TO ADVANCE THE INTERESTS OF THE AG BIOTECH INDUSTRY AND FARMERS WHO UTILIZE GMOS. MEXICO PROGRAM - DEVELOPED PROGRAMS TO PROMOTE ACCEPTANCE OF AGRICULTURAL BIOTECHNOLOGY. CANADA PROGRAM - 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 1 0 0 0 0 0 0 0 X 6 6 1 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X THE ORGANIZATION 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 X JESSICA ADELMAN CHAIR - THROUGH 6/30/2014 0.20 X X 0 0 0 JERRY FLINT DIRECTOR 0.20 X 0 0 0 MATTHIAS MEDER DIRECTOR 0.20 X 0 0 0 PHIL MILLER DIRECTOR 0.20 X 0 0 0 BRAD SHURDUT DIRECTOR 0.20 X 0 0 0 NAOMI STEVENS CHAIR - BEGINNING 7/1/2014 0.20 X X 0 0 0 CATHLEEN ENRIGHT EXECUTIVE DIRECTOR 5.00 X 0 0 0 0 0 0 0 0 0 1 KETCHUM INC 6 PPG PLACE 12TH FLOOR PITTSBURGH PA 15222 PUBLIC RELATIONS CONSULTANTS 3285163 BIOTECHNOLOGY INDUSTRY ORGANIZATION 1201 MARYLAND AVE STE 900 WASHINGTON DC 20024 MGMT SRVCS & STATE ADVOCACY 2029281 AGROBIO MEXICO AC CALDERON DE LA BARCA NO 78 PB COL. POLANCO MX 11560 PROJECT MANAGEMENT 950000 CROPLIFE CANADA 21 FOUR SEASONS PLACE SUITE 627 ETOBICOKE ONTARIO CA M9B 6J8 PROJECT MANAGEMENT 375000 ACADEMICSREVIEWORG INC PO BOX 399 PRIEST RIVER ID 83856 SCIENTIFIC OUTREACH 300000 7 MEMBERSHIP DUES & SPEC 900099 9817674 9817674 9817674 2499 2499 9820173 9817674 0 2499 X 302521 173488 48049 50117 1135660 5174514 238366 30016 11992 45836 1812 165799 9924 SPONSORSHIPS 129050 7517144 953861 682005 416735 2152540 100000 8492 49062 649260 225475 289438 423785 1668526 3407392 276468 58192 453614 107727 730082 165919 X 938444 3241473 938444 3241473 1668526 3407392 2303029 0 X X 0 1 X 1 0 0 0 0 0 0 0 1 9817674 1135660 416275 1551935 1492764 59171 3649 2098 1551 645611 223377 422234 423785 DUE TO BIOTECHNOLOGY INDUSTRY ASSOCIATION 107727 107727 X 9820173 0 9820173 0 9820173 7517141 0 7517141 3 3 7517144 PART X, LINE 2: CBI IS EXEMPT FROM FEDERAL TAXES UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE EXCEPT ON NET INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES. CBI REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. CBI DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. CBI'S IRS FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES, GENERALLY FOR THREE YEARS AFTER IT WAS FILED. PART XII, LINE 4B - OTHER ADJUSTMENTS: ROUNDING ADJUSTMENTS NORTH AMERICA - CANADA AND MEXICO 0 0 PROGRAM SERVICES CANADA: FOCUSED ON TRAINING THIRD PARTY SPOKESPEOPLE (FARMERS, ACADEMICS, DIETICIANS) TO EDUCATE MEDIA AND PUBLIC ABOUT RISK AND ABOUT THE BENEFITS OF AG BIOTECH;MEXICO: HOSTED MEDIA TRAINING AND CONFERENCES FOR STUDENTS, FARMERS, AND ACADEMICS ON THE BENEFITS OF AG BIOTECH; PARTNERED WITH GROWER GROUPS, ACADEMIA, AND FOOD CHAIN TO ENHANCE ACCEPTANCE OF AG BIOTECH; CREATED POLICY BRIEFS FOR REGULATORS. 1200000 0 0 0 0 0 0 1200000 0 1200000 0 0 0 0 0 0 PART I, LINE 3: QUARTERLY REPORTS ON ACTIVITIES AND FUNDS SPENT ARE RECEIVED FROM CANADA AND MEXICO PROGRAMS. 1 HAWAII CROP IMPROVEMENT ASSOCIATION 2111 PIILANI HWY PO BOX 629 KIIHEI HI 96753 990258882 501(C)(6) 224000 FOR OUTREACH, EDUCATION, LOBBYING AND COMMUNICATION ACTIVITIES. OREGONIANS FOR FOOD AND SHELTER 1149 COURT ST NE STE 110 SALEM OR 973014030 930775640 501(C)(6) 62521 OUTREACH AND EDUCATION EFFORTS RELATING TO BIOTECHNOLOGY RELATED MATTERS IN THE STATE OF OREGON / GRANT FOR GMO LEGAL FEES WASHINGTON FRIENDS OF FARMS & FORESTS PO BOX 7644 OLYMPIA WA 98507 911453960 501(C)(6) 10000 BIOTECHNOLOGY EDUCATION AND OUTREACH STATE AGRICULTURE AND RURAL LEADERS 6181 WEST STATE RD 28 WEST LEBANON IN 47991 204400600 501(C)(3) 6000 SARL MEMBERSHIP 1 3 PART I, LINE 2: CBI REQUIRES A FINAL REPORT 30 DAYS AFTER PROJECT COMPLETION ON HOW FUNDS WERE SPENT AND THE RESULT OF PROJECT, AND COMPARES IT TO A SIGNED PROPOSAL TO ENSURE THE FUNDS WERE SPENT FOR PURPOSES APPROVED BY CBI. X 0 0 0 FORM 990, PART VII, SECTION A, LINE 5, EXECUTIVE OFFICER COMPENSATION FORM 990, PART VII, SECTION A, LINE 5, COMPENSATION FROM UNRELATED ORGANIZATION: IN 2014, CATHLEEN ENRIGHT SERVED AS EXECUTIVE DIRECTOR FOR THE COUNCIL ON BIOTECHNOLOGY. CATHLEEN WAS EMPLOYED BY BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO), AN UNRELATED ENTITY TO THE COUNCIL FOR BIOTECHNOLOGY INFORMATION (CBI). MS. ENRIGHT PERFORMED WORK FOR CBI AND THE APPROPRIATE AMOUNT OF SALARY AND BENEFITS WERE ALLOCATED TO CBI FROM BIO. TOTAL COMPENSATION: CATHLEEN ENRIGHT (2014) - COMPENSATION $66,641 , BENEFITS $24,782. FORM 990, PART VI, SECTION A, LINE 2 CBI IS UNAWARE OF ANY OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE WHO HAS A BUSINESS OR FAMILY RELATIONSHIP WITH ANY OTHER OFFICER DIRECTOR TRUSTEE OR KEY EMPLOYEE. HOWEVER, DUE TO THE LARGE SIZE AND VARIED ACTIVITIES OF THE ORGANIZATION'S MEMBER COMPANIES, CBI BELIEVES THAT IT IS POSSIBLE THAT SUCH BUSINESS RELATIONSHIPS MAY EXIST BETWEEN MEMBERS OF THE CBI EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 3 THE EXECUTIVE COMMITTEE RESOLVED TO HAVE THE STEERING COMMITTEE ACT IN AN ADVISORY CAPACITY TO THE EXECUTIVE COMMITTEE; OVERSEE EXECUTION OF PROGRAMS IN THE UNITED STATES, CANADA, AND MEXICO; REVIEW ANNUAL BUDGET REQUESTS AND BUSINESS PLANS; REALLOCATE FUNDS AMONG PROGRAMS, AS NEEDED; AND PERFORM IN SUCH OTHER CAPACITY AS MAY BE DESIGNATED BY THE EXECUTIVE COMMITTEE. CBI HAS NO EMPLOYEES. BIOTECHNOLOGY INDUSTRY ORGANIZATION PROVIDES MANAGEMENT SERVICES TO CBI. FORM 990, PART VI, SECTION A, LINE 6 SENIOR MEMBERSHIP IS OPEN TO SIX FOUNDING MEMBERS AND OTHER CORPORATE ENTITIES THAT MEET SUCH QUALIFICATIONS AS MAY BE ESTABLISHED BY THE EXECUTIVE COMMITTEE. GENERAL MEMBERSHIP IS OPEN TO ANY CORPORATE ENTITY THAT DESIRES TO FURTHER THE PURPOSES OF THE CORPORATION AND MEETS OTHER QUALIFICATIONS AS MAY BE ESTABLISHED BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A EACH OF THE SENIOR MEMBERS APPOINTS A PERSON TO SERVE ON THE EXECUTIVE COMMITTEE, WHICH MAY EXERCISE ALL POWERS OF THE CORPORATION. FORM 990, PART VI, SECTION B, LINE 11 CBI STAFF PROVIDES THE CBI STEERING COMMITTEE (DESIGNATED BY EXECUTIVE COMMITTEE RESOLUTION TO OVERSEE DAILY OPERATIONS) THE OPPORTUNITY TO REVIEW AND MAKE COMMENTS, VIA EMAIL AND TELECONFERENCE, ON THE FORM PRIOR TO FILING. AFTER FILING, A COPY OF THE FORM 990 WILL BE PROVIDED TO THE EXECUTIVE COMMITTEE MEMBERS. FORM 990, PART VI, SECTION B, LINE 12C CBI HAS A CONFLICT OF INTEREST POLICY AND A PROCESS FOR ENSURING THAT IT IS NOT VIOLATED: AN ANNUAL STATEMENT OF DISCLOSURE IS CIRCULATED TO THE EXECUTIVE COMMITTEE MEMBERS ANNUALLY. THE EXECUTIVE COMMITTEE WILL DETERMINE WHETHER OR NOT A CONFLICT OF INTEREST EXISTS, AND WHETHER OR NOT SUCH CONFLICT MATERIALLY AND ADVERSELY AFFECTS THE INTERESTS OF CBI. AN OFFICER OR DIRECTOR WHOSE POTENTIAL CONFLICT IS UNDER REVIEW MAY NOT DEBATE, VOTE OR OTHERWISE PARTICIPATE IN SUCH DETERMINATION. IF THE EXECUTIVE COMMITTEE DETERMINES THAT AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST DOES EXIST, THE EXECUTIVE COMMITTEE ALSO SHALL DETERMINE AN APPROPRIATE REMEDY. SUCH REMEDY MAY INCLUDE, FOR EXAMPLE, THE RECUSAL OF THE CONFLICTED OFFICER OR DIRECTOR FROM PARTICIPATING IN CERTAIN MATTERS PENDING BEFORE THE EXECUTIVE COMMITTEE OR OTHER CBI BODY. CBI'S INTERNAL GOVERNANCE POLICIES STATE THAT ON AN ANNUAL BASIS, EACH MEMBER OF THE CBI EXECUTIVE COMMITTEE SHALL BE PROVIDED WITH A COPY OF THIS POLICY, AND SHALL COMPLETE AND SIGN THE ACKNOWLEDGEMENT AND DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A AS A BIO EMPLOYEE, THE COMPENSATION OF CBI'S EXECUTIVE DIRECTORS ARE DETERMINED BY BIO, AND CBI'S EXECUTIVE COMMITTEE APPROVES THE TIME ALLOCATION TO BE REIMBURSED BY CBI. THE CBI EXECUTIVE COMMITTEE CONFIRMED THE EXECUTIVE DIRECTORS' TIME ALLOCATION IN 2014. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. CBI COMPLIES WITH THE PUBLIC INSPECTION REQUIREMENTS OF INTERNAL REVENUE CODE SECTION 6104 BY MAKING ITS FORM 1024, APPLICATION FOR RECOGNITION OF EXEMPTION UNDER SECTION 501(A), DETERMINATION LETTER FROM THE IRS, AND THE FORMS 990 FOR ITS THREE MOST RECENTLY COMPLETED TAX PERIODS. HOWEVER, AS SECTION 6104 DOES NOT REQUIRE ORGANIZATIONS EXEMPT UNDER SECTION 501(C)(6) TO DISCLOSE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICIES, OR FINANCIAL STATEMENTS, CBI HAS CHOSEN NOT TO MAKE SUCH INFORMATION AVAILABLE FOR PUBLIC INSPECTION. FORM 990, PART IX, LINE 11G CONSULTING FEES INCURRED FOR GMO ANSWERS CONSULTANT 2,926,714. CONTRACTUAL SERVICES FOR MEXICO PROGRAMS 950,000. CONSULTING FEES INCURRED FOR STATE RELATIONS PROGRAMS 745,000. CONTRACTUAL SERVICES FOR SCIENTIFIC OUTREACH 300,000. CONTRACTUAL SERVICES FOR CANADA PROGRAMS 250,000. CONSULTING FEES INCURRED FOR FOCUS GROUP 2,800. FORM 990, PART XII, LINE 2C NO CHANGE IN AUDIT OVERSIGHT OR SELECTION PROCESS